Výsledky vyhledávání - "Kristiansen, Klaus T"

Prostacyclin in Mechanically Ventilated Patients with COVID-19 and Severe Endotheliopathy:A Multicenter, Randomized, Clinical Trial

Autor: Johansson, Pär I, Søe-Jensen, Peter, Bestle, Morten H, Clausen, Niels E, Kristiansen, Klaus T, Lange, Theis, Stensballe, Jakob, Perner, Anders

Publikováno v: Johansson, P I, Søe-Jensen, P, Bestle, M H, Clausen, N E, Kristiansen, K T, Lange, T, Stensballe, J & Perner, A 2022, ' Prostacyclin in Mechanically Ventilated Patients with COVID-19 and Severe Endotheliopathy : A Multicenter, Randomized, Clinical Trial ', American Journal of Respiratory and Critical Care Medicine, vol. 205, no. 3, pp. 324-329 . https://doi.org/10.1164/rccm.202108-1855OC

Rationale The mortality in SARS-CoV-2 infected patients requiring mechanical ventilation remains high and endotheliopathy has been implicated. Objective To determine the effect of prostacyclin infusion in mechanically ventilated SARS-CoV-2 infected p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2751::378ebdf3cb54cec8f3b3f4ef34400e56
https://curis.ku.dk/portal/da/publications/prostacyclin-in-mechanically-ventilated-patients-with-covid19-and-severe-endotheliopathy(8136e162-757a-4484-b96c-07266c1a6ddc).html

Zobrazit plný text záznamu

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia:The COVID STEROID 2 Randomized Trial

Autor: Munch, Marie W, Myatra, Sheila N, Vijayaraghavan, Bharath Kumar Tirupakuzhi, Saseedharan, Sanjith, Benfield, Thomas, Wahlin, Rebecka R, Rasmussen, Bodil S, Andreasen, Anne Sofie, Poulsen, Lone M, Cioccari, Luca, Khan, Mohd S, Kapadia, Farhad, Divatia, Jigeeshu V, Br��chner, Anne C, Bestle, Morten H, Helleberg, Marie, Michelsen, Jens, Padmanaban, Ajay, Bose, Neeta, M��ller, Anders, Borawake, Kapil, Kristiansen, Klaus T, Shukla, Urvi, Chew, Michelle S, Dixit, Subhal, Ulrik, Charlotte S, Amin, Pravin R, Chawla, Rajesh, Wamberg, Christian A, Shah, Mehul S, Darfelt, Iben S, J��rgensen, Vibeke L, Smitt, Margit, Granholm, Anders, Kj��r, Maj-Brit N, M��ller, Morten H, Meyhoff, Tine S, Vesterlund, Gitte K, Hammond, Naomi E, Micallef, Sharon, Bassi, Abhinav, John, Oommen, Jha, Anubhuti, Cronhjort, Maria, Jakob, Stephan M, Gluud, Christian, Lange, Theis, Kadam, Vaijayanti, Marcussen, Klaus V, Hollenberg, Jacob, Hedman, Anders, Nielsen, Henrik, Schj��rring, Olav L, Jensen, Marie Q, Leistner, Jens W, Jonassen, Trine B, Kristensen, Camilla M, Clapp, Esben C, Hjorts��, Carl J S, Jensen, Thomas S, Halstad, Liv S, Bak, Emilie R B, Zaabalawi, Reem, Metcalf-Clausen, Matias, Abdi, Suhayb, Hatley, Emma V, Aksnes, Tobias S, Gleipner-Andersen, Emil, Alarc��n, Arif F, Yamin, Gabriel, Heymowski, Adam, Berggren, Anton, La Cour, Kirstine, Weihe, Sarah, Pind, Alison H, Engstr��m, Janus, Jha, Vivekanand, Venkatesh, Balasubramanian, Perner, Anders

Publikováno v: COVID STEROID 2 Trial Group, Rasmussen, B S, Nielsen, H & Schjørring, O L 2021, ' Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia : The COVID STEROID 2 Randomized Trial ', JAMA: The Journal of the American Medical Association, vol. 326, no. 18, pp. 1807-1817 . https://doi.org/10.1001/jama.2021.18295
Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Saseedharan, S, Benfield, T, Wahlin, R R, Rasmussen, B S, Andreasen, A S, Poulsen, L M, Cioccari, L, Khan, M S, Kapadia, F, Divatia, J V, Brochner, A C, Bestle, M H, Helleberg, M, Michelsen, J, Padmanaban, A, Bose, N, Møller, A, Borawake, K, Kristiansen, K T, Shukla, U, Chew, M S, Dixit, S, Ulrik, C S, Amin, P R, Chawla, R, Wamberg, C A, Shah, M S, Darfelt, I S, Jorgensen, V L, Smitt, M, Granholm, A, Kjær, M-B N, Møller, M H, Meyhoff, T S, Vesterlund, G K, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, A, Cronhjort, M, Jakob, S M, Gluud, C, Lange, T, Kadam, V, Marcussen, K V, Hollenberg, J, Hedman, A, Nielsen, H, Schjorring, O L, Jensen, M Q, Leistner, J W, Jonassen, T B, Kristensen, C M, Clapp, E C, Hjortso, C J S, Jensen, T S, Halstad, L S, Bak, E R B, Zaabalawi, R, Metcalf-Clausen, M, Abdi, S, Hatley, E V, Aksnes, T S, Gleipner-Andersen, E, Alarcon, A F, Yamin, G, Heymowski, A, Berggren, A, La Cour, K, Weihe, S, Pind, A H, Engstrom, J, Jha, V, Venkatesh, B & Perner, A 2021, ' Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia The COVID STEROID 2 Randomized Trial ', J A M A: The Journal of the American Medical Association, vol. 326, no. 18, pp. 1807-1817 . https://doi.org/10.1001/jama.2021.18295
COVID STEROID 2 Trial Group 2021, ' Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia : The COVID STEROID 2 Randomized Trial ', JAMA: The Journal of the American Medical Association, vol. 326, no. 18, pp. 1807-1817 . https://doi.org/10.1001/jama.2021.18295
The COVID STEROID 2 Trial Group 2021, ' Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive without Life Support in Adults with COVID-19 and Severe Hypoxemia : The COVID STEROID 2 Randomized Trial ', JAMA-Journal of the American Medical Association, vol. 326, no. 18, pp. 1807-1817 . https://doi.org/10.1001/jama.2021.18295

Importance A daily dose with 6 mg of dexamethasone is recommended for up to 10 days in patients with severe and critical COVID-19, but a higher dose may benefit those with more severe disease. Objective To assess the effects of 12 mg/d vs 6 mg/d of d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3adc4ced93a6a128adc2824e55d4fc00
https://vbn.aau.dk/da/publications/04a329c2-9c2e-411e-8d5b-9bf36f405df6

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání